Медико-соціальне обґрунтування мультимодальної системи профілактики артеріальної гіпертензії на основі концепції персоналізованої медицини у дорослого населення на регіональному рівні

57. Лашкул З.В. Смертність від гіпертонічної хвороби: достовірність кодування лікарських свідоцтв про смерть в первинній ланці охорони здоров'я /З.В. Лашкул //Wiadomosci Lekarskie -Польща, 2014.-№2. -С.207-209.

58. Серцево-судинна захворюваність в Україні та рекомендації щодо покращення здоров'я в сучасних умовах: аналітично-статистичний посібник/ [В.М. Корнацький, А.П. Дорогой та ын.]. - Київ, 2012. -117с.

59. Основні показники інвалідності та діяльності медико-соціальних експертних комісій України за 2013 рік: аналітично - інформаційний довідник / [С.І. Черняк, А.В. Іпатов, О.М. Мороз та ін.]. - Дніпропетровськ: «Пороги», 2014.

60. Європейська база даних ЗДВ 2007 - 2014 р.р.

61. Наказ МОЗ України від 24.05.2012р. №384 Про затвердження та впровадження медико-технологічної документації зі стандартів медичної допомоги при АГ.

62. Лашкул З.В. Анализ ошибок кодирования причин смерти при заболеваниях органов кровообращения в первичном звене здравоохранения /З.В.Лашкул // Профилактическая медицина. - Москва, 2014. - №5. - С.70-72.

63. Погорелова Э.И. Об ошибках при заполнении медицинского свидетельства о смерти / Э.И. Погорелова // Проблемы социальной гигиены здравоохранения и истории медицины. - 2007. - №1. - С.43-47.

64. Оценка достоверности кодирования причин смерти: опубликовано в электронном научном журнале "Социальные аспекты здоровья населения /К.В. Лопаков. - 2011.

65. Приказ МОЗ Украины №545 от 08.08.2006 года. Инструкция заполнения и выдачи врачебного свидетельства о смерти (форма №106/0).

66. Самородская И.В. Сердечно-сосудистые заболевания: принципы статистического учета в разных странах [Текст]/ И. В. Самородская //Здравоохранение. - 2009. - №7. - С. 7-11.

67. Никулин Н.Н. Сердечно-сосудистая смертность: анализ качества, диагностики и статистического учета причин смерти / Н.Н. Никулин //Саратовский научно-медицинский журнал. - 2011. -№ 1,(7). - С.4-8.

68. Погорелов Э.И. Об ошибках при заполнении медицинского свидетельства о смерти. Проблемы социальной гигиены, здравоохранения и истории медицины. /Э.И. Погорелов -Россия, 2007. -№ 1. -С.43-47.

69. How to use the statistics of causes of death? /Rasika Rampatige, Lene Mikkelsen, Bernardo Hernandez, [et al.]// Bull - World Health Organ, 2014. -№.92. -P.3-3A.

70. Бойцов С.А. От профилактической кардиологии к профилактике неинфекционных заболеваний в России/ С.А. Бойцов, Р.Г. Оганов //Российский кардиологический журнал. - 2013. -№4, (102). - С. 6-13.

71. Рингач Н.О. Погляд на проблему передчасної смертності населення України крізь призму національної безпеки /Н.О. Рингач //Стратегічні пріоритети. -2008. - №1. -С.102-111.

72. Сердечно-сосудистая заболеваемость и смертность - статистика по европейским странам (2008)//Medicine review. -2009.-№1, (06). -С.6-12.

73. Офіційний сайт Всесвітньої організації охорони здоров'я.

74. Disability-adjusted life years (dalys) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010 / C. J. L. Murray, T. Vos, R. Lozano[et al.] // Lancet. - England: London, 2012. -- Vol. 380, No. 9859. -- P. 2197-2223.

75. Verberk W.J. Prevalence, causes, and consequences of masked hypertension: a meta-analysis / W. J. Verberk, A. G. H. Kessels, P. W. de Leeuw // American Journal of Hypertension. -- 2008. -- Vol. 21, No. 9. -- P. 969-975.

76. Stiles S. Framingham Criteria Predict New Hypertension Better Than Prehypertension in Young Adults [Electronic resource] /S. Stiles // Medscape Medical News. - 2013. - Available from: http://www.medscape.com/viewarticle/811416.

77. Evaluating the framingham hypertension risk prediction model in young adults: the coronary artery risk development in young adults (cardia) study / A. P. Carson, C. E. Lewis, D. R. Jacobs[et al.] // Hypertension. -- 2013. -- Vol. 62, No. 6. -- P. 1015-1020.

78. General cardiovascular risk profile for use in primary care: the framingham heart study / R. B. D'Agostino, R. S. Vasan, M. J. Pencina[et al.] // Circulation. -- 2008. -- Vol. 117, No. 6. -- P. 743-753.

79. Risk models to predict hypertension: [a systematic review] / J. B. Echouffo-Tcheugui, G. D. Batty, M. Kivimдki, A. P. Kengne // PloS One. -- 2013. -- Vol. 8, No. 7. -- P. e67370.

80. Клінічні рекомендації по профілактиці АГ ESH/ESC 2003р.

81. Клінічні рекомендації по профілактиці АГ ESH/ESC 2007р.

82. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials / J. E. Neter, B. E. Stam, F. J. Kok[et al.] // Hypertension. -- 2003. -- Vol. 42, No. 5. -- P. 878-884.

83. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis / K. M. Flegal, B. K. Kit, H. Orpana, B. I. Graubard // JAMA. -- 2013. -- Vol. 309, No. 1. -- P. 71-82.

84. Бойцов С.А. Структура факторов сердечно-сосудистого риска и качество мер их профилактики в первичном звене здравоохранения в России и в Европейских странах (по результатам исследования ЕURIKA) /С.А. Бойцов // Кардиоваскулярная терапия и профилактика. -2012. -№2. - С.11-16.

85. Gaciong Z. Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses / Z. Gaciong, M. Siсski, J. Lewandowski // Current Hypertension Reports. -- 2013. -- Vol. 15, No. 6. -- P. 559-574.

86. The japanese society of hypertension guidelines for the management of hypertension (jsh 2009) / T. Ogihara, K. Kikuchi, H. Matsuoka[et al.] // Hypertension Research: Official Journal of the Japanese Society of Hypertension. -- 2009. -- Vol. 32, No. 1. -- P. 3-107.

87. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis / K. M. Flegal, B. K. Kit, H. Orpana, B. I. Graubard // JAMA. -- 2013. -- Vol. 309, No. 1. -- P. 71-82.

88. Cornelissen V. A. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors / V. A. Cornelissen, R. H. Fagard // Hypertension. -- 2005. -- Vol. 46, No. 4. -- P. 667-675.

89. Fagard R. H. Exercise therapy in hypertensive cardiovascular disease / R. H. Fagard // Progress in Cardiovascular Diseases. -- 2011. -- Vol. 53, No. 6. -- P. 404-411.

90. Результаты первого этапа мониторинга эпидемиологической ситуации по артериальной гипертонии в Российской Федерации (2003 - 2004г.г.), проведенного в рамках федеральной целевой программы «Профилактика и лечение артериальной гипертонии в Российской Федерации» [Текст] : [информационно-статистический сборник]. - М., 2005.- 144с.

91. Quality improvement strategies for hypertension management: a systematic review / J. M. E. Walsh, K. M. McDonald, K. G. Shojania[et al.] // Medical Care. -- 2006. -- Vol. 44, No. 7. -- P. 646-657.

92. Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients / L. P. Svetkey, K. I. Pollak, W. S. Yancy[et al.] // Hypertension. -- 2009. -- Vol. 54, No. 6. -- P. 1226-1233.

93.Hypertension prevalence, awareness, and control in arab countries: a systematic review / A. Tailakh, L. S. Evangelista, J. C. Mentes[et al.] // Nursing & Health Sciences. -- 2014. -- Vol. 16, No. 1. -- P. 126-130.

94.A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010 / S. S. Lim, T. Vos, A. D. Flaxman[et al.] // Lancet. - London: England, 2012. -- Vol. 380, No. 9859. -- P. 2224-2260.

95.Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east asians / N. Kato, F. Takeuchi, Y. Tabara[et al.] // Nature Genetics. -- 2011. -- Vol. 43, No. 6. -- P. 531-538.

96.Modesti P. A. Need for better blood pressure measurement in developing countries to improve prevention of cardiovascular disease / P. A. Modesti, E. Perruolo, G. Parati // Journal of Epidemiology. -- 2015. -- Vol. 25, No. 2. -- P. 91-98.

97.Prevalence of the main cardiovascular risk factors in morocco: results of a national survey, 2000 / M. A. Tazi, S. Abir-Khalil, N. Chaouki[et al.] // Journal of Hypertension. -- 2003. -- Vol. 21, No. 5. -- P. 897-903.

98.Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study / M. J. O'Donnell, D. Xavier, L. Liu[et al.] // Lancet. - London: England, 2010. -- Vol. 376, No. 9735. -- P. 112-123.

99.Educational disparities in distribution of cardiovascular risk factors and quality of care in korean adults: korean national health and nutrition survey iv / J.-M. Yoon, J.-H. Kim, B.-S. Suh, S. M. Park // Korean Journal of Family Medicine. -- 2013. -- Vol. 34, No. 1. -- P. 27-35.

100.Effectiveness of community-based comprehensive healthy lifestyle promotion on cardiovascular disease risk factors in a rural vietnamese population: a quasi-experimental study / Q. N. Nguyen, S. T. Pham, V. L. Nguyen[et al.] // BMC cardiovascular disorders. -- 2012. -- Vol. 12. -- 56p.

101.Global Status Report on Noncommunicable Diseases 2010 [Electronic resource] - WHO, 2013 - Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf.

102.Профілактика і лікування артеріальної гіпертензії в Україні: матеріали Всеукраїнської науково - практичної конференції, (Київ, 17-19 травня 2010 р.) // Український кардіологічний журнал. - Додаток 1. -2010. - С.6-12.

103.Доклад о состоянии здравоохранения в Европе 2009г. // Региональные публикации ВОЗ, Европейская серия. - ЕРБ ВОЗ, 2009. - №97. - 156 с.

104.Глобальный доклад о ходе работы по неинфекционным болезням 2010. - ВОЗ, 2013. - Режим доступа: http: //www.who.int/nmh/publications/ncd_report_full_en.pdf.

105.The relationship between lifestyle and self-reported health in a general population: the inter99 study / C. Pisinger, U. Toft, M. Aadahl[et al.] // Preventive Medicine. -- 2009. -- Vol. 49, No. 5. -- P. 418-423.

106.Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to hypertension in the very elderly randomised controlled trial / N. Beckett, R. Peters, J. Tuomilehto[et al.] // BMJ (Clinical research ed.). -- 2012. -- Vol. 344. -- d7541p.

107.Rapeport N. Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the centralised pan-south african survey on the under-treatment of hypercholesterolaemia (cepheus sa) study / N. Rapeport, C. L. Schamroth, D. J. Blom // Cardiovascular Journal of Africa. -- 2013. -- Vol. 24, No. 6. -- P. 238-242.

108. Predicting the risk of incident hypertension in a korean middle-aged population: korean genome and epidemiology study / N.K. Lim, K.H. Son, K.S. Lee[et al.] // Journal of Clinical Hypertension (Greenwich, Conn.). -- 2013. -- Vol. 15, No. 5. -- P. 344-349.

109.Gaciong Z. Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses / Z. Gaciong, M. Siсski, J. Lewandowski // Current Hypertension Reports. -- 2013. -- Vol. 15, No. 6. -- P. 559-574.

110.Quality improvement strategies for hypertension management: a systematic review / J. M. E. Walsh, K. M. McDonald, K. G. Shojania[et al.] // Medical Care. -- 2006. -- Vol. 44, No. 7. -- P. 646-657.

111.Do men and women respond differently to blood pressure-lowering treatment? results of prospectively designed overviews of randomized trials / F. Turnbull, M. Woodward, B. Neal[et al.] // European Heart Journal. -- 2008. -- Vol. 29, No. 21. -- P. 2669-2680.

112.The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review / A. Beratarrechea, A. G. Lee, J. M. Willner[et al.] // Telemedicine Journal and E-Health: The Official Journal of the American Telemedicine Association. -- 2014. -- Vol. 20, No. 1. -- P. 75-82.

113.Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association / K. L. Furie, S. E. Kasner, R. J. Adams[et al.] // Stroke; a Journal of Cerebral Circulation. -- 2011. -- Vol. 42, No. 1. -- P. 227-276.

114.Secondary preventive medication persistence and adherence 1 year after stroke / C. D. Bushnell, D. M. Olson, X. Zhao[et al.] // Neurology. -- 2011. -- Vol. 77, No. 12. -- P. 1182-1190.

115.Коваленко В.М. Региональные медико-социальные проблеми заболеваний органов кровообращения /Коваленко В.М. - Киев, 2013. - 240 с.

116.Серцево-судинна захворюваність в Україні та рекомендації щодо покращення здоров'я в сучасних умовах: аналітично-статистичний посібник/ [В.М.Корнацький, А.П. Дорогой та ін.]. - Київ, 2012. -117с.

117.Александров А.А. Профилактика сердечно-сосудистых заболеваний с детства: проблемы, успехи/ А.А. Александров //Кардиоваскулярная терапия и профилактика. -2012.- №2. - С.96-103.

118.Соціально-гігієнічне дослідження гіпертонічної хвороби серед людей похилого віку: збірник наукових праць / З.В.Лашкул, В.Ф. Посний, В.С. Авраменко [ та інш.]. - ЗМАПО, 2011. -С.209-212.

119.Бадалянц И.Е. О профилактике сердечно-сосудистых заболеваний у лиц старшего возраста в Самарской области [Текст] / И.Е. Бадалянц // Клиническая геронтология. -2008. - Т. 14, № 8. - С. 59-61.

120.Некоторые поведенческие факторы риска развития сердечно-сосудистых заболеваний у мужчин средних возрастных групп: терапевтический архив / Е.В Акимова , В.А. Кузнецов , В.В. Гафаров [и др.]. - 2009. -№1,(81).- С.56-60.

121.Александров А.А. Профилактика сердечно-сосудистых заболеваний с детства: проблемы, успехи/ А.А. Александров //Кардиоваскулярная терапия и профилактика. -2012.- №2. - С.96-103.

122.Cost-effectiveness of a hypertension management programme in an elderly population: a markov model / [G. Perman, E. Rossi, G. D. Waisman et al.] // Cost Effectiveness and Resource Allocation: C/E. -- 2011. -- Vol. 9, No. 1. -- 4p.

123.Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the coronary artery risk development in (young) adults (cardia) study / K. Liu, M. L. Daviglus, C. M. Loria[et al.] // Circulation. -- 2012. -- Vol. 125, No. 8. -- P. 996-1004.

124.National surveillance definitions for hypertension prevalence and control among adults / M. T. Crim, S. S. S. Yoon, E. Ortiz[et al.] // Circulation. Cardiovascular Quality and Outcomes. -- 2012. -- Vol. 5, No. 3. -- P. 343-351.

125.Hypertension awareness, treatment, and control--continued disparities in adults: united states, 2005-2006 / Y. Ostchega, S. S. Yoon, J. Hughes, T. Louis // NCHS data brief. -- 2008. -- No. 3. -- P. 1-8.

126.Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial / [T. H. Jafar, M. Islam, J. Hatcher et al.] // BMJ (Clinical research ed.). -- 2010. -- Vol. 340. -- c2641p.

127.Age at stroke: temporal trends in stroke incidence in a large, biracial population / B. M. Kissela, J. C. Khoury, K. Alwell [et al.] // Neurology. -- 2012. -- Vol. 79, No. 17. -- P. 1781-1787.

128.Барна О.М. Статеві особливості проявів артеріальної гіпертензії як фактора ризику ІХС /О.М. Барна, Л.П Вовк // Сімейна медицина. -2004. - № 4. - С. 49-51.

129.Оганов Р.Г. Гендерные различия кардиоваскулярной патологии/ Р.Г. Оганов, Г.Я. Масленникова //Кардмоваскулярная терапия и профилактика. - 2012. -№4. - С.101-105.

130.Бобров В.О. Артеріальна гіпертензія у жінок в період менопаузи: особливості діагностики, диференційоване лікування: методичні рекомендації / Бобров В.О., Давидова І.В., Венцківський Б.М. - Київ, 2000. - 25с.

131.Давыдова И.В. Риск сердечно-сосудистых заболеваний у женщин в зависимости от гормонального континуума /И.В. Давыдова // Мистецтво лікування. - 2008. - № 3 (49). - С. 90-96.

132.Подзолков В.И. Эссенциальная артериальная гипертензия у женщин или женская артериальная гипертензия? / В.И. Подзолков, А.Е. Брагина //Кардиоваскулярная терапия и профилактика. - 2012. - №1. - С.79-85.

133.Bersamin A. Predictors of hypertension awareness, treatment, and control among mexican american women and men / A. Bersamin, R. S. Stafford, M. A. Winkleby // Journal of General Internal Medicine. -- 2009. -- Vol. 24 Suppl 3. -- P. 521-527.

134. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women / J. Boggia, L. Thijs, T. W. Hansen[et al.] // Hypertension. -- 2011. -- Vol. 57, No. 3. -- P. 397-405.

135.Blood pressure categories and long-term risk of cardiovascular disease according to age group in japanese men and women / A. Fujiyoshi, T. Ohkubo, K. Miura[et al.] // Hypertension Research: Official Journal of the Japanese Society of Hypertension. -- 2012. -- Vol. 35, No. 9. -- P. 947-953.

136.Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (sparcl) study / L. B. Goldstein, P. Amarenco, M. Lamonte[et al.] // Stroke; a Journal of Cerebral Circulation. -- 2008. -- Vol. 39, No. 9. -- P. 2444-2448.

137.Gender differences in the age-stratified prevalence of risk factors in korean ischemic stroke patients: a nationwide stroke registry-based cross-sectional study / T. H. Park, Y. Ko, S. J. Lee[et al.] // International Journal of Stroke: Official Journal of the International Stroke Society. -- 2014. -- Vol. 9, No. 6. -- P. 759-765.

138. Gender gap in cerebrovascular accidents: comparison of the extent, severity, and risk factors in men and women aged 45-65 / D. Hochner-Celnikier, O. Manor, B. Garbi, T. Chajek-Shaul // International Journal of Fertility and Women's Medicine. -- 2005. -- Vol. 50, No. 3. -- P. 122-128.

139.Baghshomali S. Reducing stroke in women with risk factor management: blood pressure and cholesterol / S. Baghshomali, C. Bushnell // Women's Health. - London: England, 2014. -- Vol. 10, No. 5. -- P. 535-544

140.Некоторые поведенческие факторы риска развития сердечно-сосудистых заболеваний у мужчин средних возрастных групп: терапевтический архив/ Е.В. Акимова, В.А. Кузнецов, В.В. Гафаров [.и др.]. - 2009. -№1,(81).- С.56-60.

141.Thunander Sundbom L. Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide swedish survey / L. Thunander Sundbom, K. Bingefors // Pharmacy Practice. -- 2012. -- Vol. 10, No. 4. -- P. 207-221.

142.Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in u.s. adults, 1999-2006 / C. D. Fryar, R. Hirsch, M. S. Eberhardt[et al.] // NCHS data brief. -- 2010. -- No. 36. -- P. 1-8.

143.Millis R. M. Epigenetics and hypertension / R. M. Millis // Current Hypertension Reports. -- 2011. -- Vol. 13, No. 1. -- P. 21-28.

144.Brown M. J. Hypertension and ethnic group / M. J. Brown // BMJ (Clinical research ed.). -- 2006. -- Vol. 332, No. 7545. -- P. 833-836.

145.Слабкий Г.О. Передчасна смертність чоловіків працездатного віку Львівської області від хвороб системи кровообігу / Г.О. Слабкий, Ю.Б Ющенко, О.М. Орда [та ін.] //Здоров'я і суспільство. - 2011. - №1. - С.5-9.

146.Crouch R. A systematic review of the effectiveness of primary health education or intervention programs in improving rural women's knowledge of heart disease risk factors and changing lifestyle behaviours / R. Crouch, A. Wilson, J. Newbury // International Journal of Evidence-Based Healthcare. -- 2011. -- Vol. 9, No. 3. -- P. 236-245.

147. Мурясова Э.Б. Медико-социальная профилактика артериальной гипертонии городского населения с учетом типа семьи [Текст]: автореф.дис. канд. мед. наук. / Э.Б. Мурясова. - Уфа: БГМУ, 2003. - 23 с.

148.Wang T. J. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction / T. J. Wang // Circulation. -- 2011. -- Vol. 123, No. 5. -- P. 551-565.

149.Multiple biomarkers for the prediction of first major cardiovascular events and death / T. J. Wang, P. Gona, M. G. Larson[et al.] // The New England Journal of Medicine. -- 2006. -- Vol. 355, No. 25. -- P. 2631-2639.

150.Use of multiple biomarkers to improve the prediction of death from cardiovascular causes / B. Zethelius, L. Berglund, J. Sundstrцm[et al.] // The New England Journal of Medicine. -- 2008. -- Vol. 358, No. 20. -- P. 2107-2116.

151.Association between a literature-based genetic risk score and cardiovascular events in women / N. P. Paynter, D. I. Chasman, G. Parй[et al.] // JAMA. -- 2010. -- Vol. 303, No. 7. -- P. 631-637.

152.Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in swedes / C. Fava, M. Sjцgren, M. Montagnana[et al.] // Hypertension. -- 2013. -- Vol. 61, No. 2. -- P. 319-326.

153.Prediction models for the risk of new-onset hypertension in ethnic chinese in taiwan / K.-L. Chien, H.-C. Hsu, T.-C. Su[et al.] // Journal of Human Hypertension. -- 2011. -- Vol. 25, No. 5. -- P. 294-303.

154.The mediterranean diet and incidence of hypertension: the seguimiento universidad de navarra (sun) study / J. M. Nъсez-Cуrdoba, F. Valencia-Serrano, E. Toledo[et al.] // American Journal of Epidemiology. -- 2009. -- Vol. 169, No. 3. -- P. 339-346.

155.Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in japanese men / K. Ishikawa-Takata, T. Ohta, K. Moritaki[et al.] // European Journal of Clinical Nutrition. -- 2002. -- Vol. 56, No. 7. -- P. 601-607.

156.Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials / J. E. Neter, B. E. Stam, F. J. Kok[et al.] // Hypertension. -- 2003. -- Vol. 42, No. 5. -- P. 878-884.

157.Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies / G. Whitlock, S. Lewington[et al.] // Lancet. -- 2009. -- Vol. 373, No. 9669. -- P. 1083-1096.

158.Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis / K. M. Flegal, B. K. Kit, H. Orpana, B. I. Graubard // JAMA. -- 2013. -- Vol. 309, No. 1. -- P. 71-82.

159.Exercise for overweight or obesity / K. Shaw, H. Gennat, P. O'Rourke, C. Del Mar // The Cochrane Database of Systematic Reviews. -- 2006. -- No. 4. -- P. CD003817.

160.Long-term non-pharmacological weight loss interventions for adults with prediabetes / [S. L. Norris, X. Zhang, A. Avenell et al.] // The Cochrane Database of Systematic Reviews. -- 2005. -- No. 2. -- P. CD005270.

161.A community programme to reduce salt intake and blood pressure in ghana [isrctn88789643] / [F. P. Cappuccio, S. M. Kerry, F. B. Micah et al.] // BMC public health. -- 2006. -- Vol. 6. -- 13p.

162.Salt reduction initiatives around the world / J. L. Webster, E. K. Dunford, C. Hawkes, B. C. Neal // Journal of Hypertension. -- 2011. -- Vol. 29, No. 6. -- P. 1043-1050.

163.Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use / P. Asaria, D. Chisholm, C. Mathers[et al.] // Lancet. - London: England, 2007. -- Vol. 370, No. 9604. -- P. 2044-2053.

164.Association between alpha-adducin gene polymorphism (gly460trp) and genetic predisposition to salt sensitivity: a meta-analysis / R. Wang, B. Zhong, Y. Liu, C. Wang // Journal of Applied Genetics. -- 2010. -- Vol. 51, No. 1. -- P. 87-94.

165.Association between alpha-adducin gene polymorphism (gly460trp) and genetic predisposition to salt sensitivity: a meta-analysis / R. Wang, B. Zhong, Y. Liu, C. Wang // Journal of Applied Genetics. -- 2010. -- Vol. 51, No. 1. -- P. 87-94.

166.Effect of lower sodium intake on health: systematic review and meta-analyses / [Aburto N. J., Ziolkovska A., Hooper L. et al.] // BMJ (Clinical research ed.). -- 2013. -- Vol. 346. -- f1326p.

167. Sodium intake in populations: assessment of evidence [Electronic Resources]. - Institute of Medicine of the National Academies, 2014. -Available at: www.iom.edu/ sodiumconsequences.

168.Guideline: sodium intake for adults and children. - Geneva: World Health Organization, 2012.

169.Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis / C. M. Smith-Spangler, J. L. Juusola, E. A. Enns[et al.] // Annals of Internal Medicine. -- 2010. -- Vol. 152, No. 8. -- P. 481-487, W170-173.

170.Effect of lower sodium intake on health: systematic review and meta-analyses / [N. J. Aburto, A. Ziolkovska, L. Hooper et al.] // BMJ (Clinical research ed.). -- 2013. -- Vol. 346. -- P. f1326.

171.Law M. R. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies / M. R. Law, J. K. Morris, N. J. Wald // BMJ (Clinical research ed.). -- 2009. -- Vol. 338. -- P. b1665..

172.Feasibility of treating prehypertension with an angiotensin-receptor blocker / S. Julius, S. D. Nesbitt, B. M. Egan[et al.] // The New England Journal of Medicine. -- 2006. -- Vol. 354, No. 16. -- P. 1685-1697.

173.The pharao study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the german hypertension league / S. Lьders, J. Schrader, J. Berger[et al.] // Journal of Hypertension. -- 2008. -- Vol. 26, No. 7. -- P. 1487-1496.

174.Treatment of hypertension in patients 80 years of age or older / N. S. Beckett, R. Peters, A. E. Fletcher[et al.] // The New England Journal of Medicine. -- 2008. -- Vol. 358, No. 18. -- P. 1887-1898.

175.Principal results of the japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (jatos) // Hypertension Research: Official Journal of the Japanese Society of Hypertension. -- JATOS Study Group, 2008. -- Vol. 31, No. 12. -- P. 2115-2127.

176.High fruit intake is associated with a lower risk of future hypertension determined by home blood pressure measurement: the ohasama study / M. Tsubota-Utsugi, T. Ohkubo, M. Kikuya[et al.] // Journal of Human Hypertension. -- 2011. -- Vol. 25, No. 3. -- P. 164-171.

177.Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: intermap study / H. Ueshima, J. Stamler, P. Elliott[et al.] // Hypertension. -- 2007. -- Vol. 50, No. 2. -- P. 313-319.

178.Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in japanese populations: the japan public health center-based (jphc) study cohort i / Y. Kokubo, H. Iso, J. Ishihara[et al.] // Circulation. -- 2007. -- Vol. 116, No. 22. -- P. 2553-2562.

179.Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (life): a randomised trial against atenolol / B. Dahlцf, R. B. Devereux, S. E. Kjeldsen[et al.] // Lancet (London, England). -- 2002. -- Vol. 359, No. 9311. -- P. 995-1003.

180.Principal results of the controlled onset verapamil investigation of cardiovascular end points (convince) trial / H. R. Black, W. J. Elliott, G. Grandits[et al.] // JAMA. -- 2003. -- Vol. 289, No. 16. -- P. 2073-2082.

181.A calcium antagonist vs a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil- Trandolapril Study (INVEST): a randomized controlled trial. / C.J. Pepine, E.M.Handberg, R.M. Cooper-De Hoff [et al.] //JAMA. - INVEST investigators, 2003. - Vol.290. -P. 2805-2816.

182.Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the swedish trial in old patients with hypertension-2 study / L. Hansson, L. H. Lindholm, T. Ekbom[et al.] // Lancet. - London: England, 1999. -- Vol. 354, No. 9192. -- P. 1751-1756.

183.Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the nordic diltiazem (nordil) study / L. Hansson, T. Hedner, P. Lund-Johansen[et al.] // Lancet (London, England). -- 2000. -- Vol. 356, No. 9227. -- P. 359-365.

184.Mancia G. New-onset diabetes and antihypertensive drugs / G. Mancia, G. Grassi, A. Zanchetti // Journal of Hypertension. -- 2006. -- Vol. 24, No. 1. -- P. 3-10.

185.Vidt D. G. Telmisartan, ramipril, or both in patients at high risk for vascular events / D. G. Vidt // Current Hypertension Reports. -- 2008. -- Vol. 10, No. 5. -- P. 343-344.

186.Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin ii receptor blocker on central aortic pressure in hypertensive patients / Y. Matsui, K. Eguchi, M. F. O'Rourke[et al.] // Hypertension. -- 2009. -- Vol. 54, No. 4. -- P. 716-723.

187.Gupta A. K. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis / A. K. Gupta, S. Arshad, N. R. Poulter // Hypertension. -- 2010. -- Vol. 55, No. 2. -- P. 399-407.

188.Claxton A. J. A systematic review of the associations between dose regimens and medication compliance / A. J. Claxton, J. Cramer, C. Pierce // Clinical Therapeutics. -- 2001. -- Vol. 23, No. 8. -- P. 1296-1310.

189.Effects of a polypill (polycap) on risk factors in middle-aged individuals without cardiovascular disease (tips): a phase ii, double-blind, randomised trial: Indian Polycap Study (TIPS) /S. Yusuf, P. Pais[et al.] // Lancet. - London: England, 2009. -- Vol. 373, No. 9672. -- P. 1341-1351.

190.Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. systolic hypertension in europe (syst-eur) trial investigators / R. H. Fagard, J. A. Staessen, L. Thijs[et al.] // Circulation. -- 2000. -- Vol. 102, No. 10. -- P. 1139-1144.

191.Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men / K. Bjцrklund, L. Lind, B. Zethelius[et al.] // Circulation. -- 2003. -- Vol. 107, No. 9. -- P. 1297-1302.

192.Mortality and morbidity results from the european working party on high blood pressure in the elderly trial / A. Amery, W. Birkenhдger, P. Brixko[et al.] // Lancet. - London: England, 1985. -- Vol. 1, No. 8442. -- P. 1349-1354.

193.Medical research council trial of treatment of hypertension in older adults: principal results. mrc working party // BMJ (Clinical research ed.). -- 1992. -- Vol. 304, No. 6824. -- P. 405-412.

194.Association of blood pressure in late adolescence with subsequent mortality: cohort study of swedish male conscripts / J. Sundstrцm, M. Neovius, P. Tynelius, F. Rasmussen // BMJ (Clinical research ed.). -- 2011. -- Vol. 342. -- P. d643.

195.Representation of women in randomized clinical trials of cardiovascular disease prevention / C. Melloni, J. S. Berger, T. Y. Wang[et al.] // Circulation. Cardiovascular Quality and Outcomes. -- 2010. -- Vol. 3, No. 2. -- P. 135-142.

196.Low rate of sex-specific result reporting in cardiovascular trials / L. A. Blauwet, S. N. Hayes, D. McManus[et al.] // Mayo Clinic Proceedings. -- 2007. -- Vol. 82, No. 2. -- P. 166-170.

197.Impaired adaptation of cardiopulmonary receptors to western diet in normotensive black immigrants / P. A. Modesti, M. I. Hagi, V. Corsoni[et al.] // American Journal of Hypertension. -- 1999. -- Vol. 12, No. 2 Pt 1. -- P. 145-150.

198.Polymorphisms associated with cholesterol and risk of cardiovascular events / S. Kathiresan, O. Melander, D. Anevski[et al.] // The New England Journal of Medicine. -- 2008. -- Vol. 358, No. 12. -- P. 1240-1249.

199.Global Status Report on Alcohol and Health //World Health Organization. - Le Mont - sur-Lausanne, Switzerland L'IV COM Sarl, 2011. - 277р.

200.Масленикова Г.Я. Алкоголь и риск развития неинфекционных заболеваний: стратегии контроля в Российской Федерации/ Г.Я. Масленикова, Р.Г. Оганов //Кардиоваскулярная терапия и профилактика. - 2013. -№4. - С.4-9.

201.Оганов Р.Г. Алкогольная единица и дозы потребления алкоголя: медицинские и социально-эекономические аспекты/ Оганов Р.Г., Масленникова

Г.Я., Лепехин В.А. //Профилактическая медицина. -2010. -№5. -С.17-22.

202.Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis / P. E. Ronksley, S. E. Brien, B. J. Turner[et al.] // BMJ (Clinical research ed.). -- 2011. -- Vol. 342. -- d671р.

203. Roerecke M. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis / M. Roerecke, J. Rehm // American Journal of Epidemiology. -- 2010. -- Vol. 171, No. 6. -- P. 633-644.

204.Lawhon M. Alcohol control in the news: the politics of media representations of alcohol policy in south africa / M. Lawhon, C. Herrick // Journal of Health Politics, Policy and Law. -- 2013. -- Vol. 38, No. 5. -- P. 987-1021.

205.Jernigan D. H. Measuring youth exposure to alcohol marketing on social networking sites: challenges and prospects / D. H. Jernigan, A. E. Rushman // Journal of Public Health Policy. -- 2014. -- Vol. 35, No. 1. -- P. 91-104.

206.Winpenny E. M. Exposure of children and adolescents to alcohol marketing on social media websites / E. M. Winpenny, T. M. Marteau, E. Nolte // Alcohol and Alcoholism (Oxford, Oxfordshire). -- 2014. -- Vol. 49, No. 2. -- P. 154-159.

207.Global status report on alcohol and health. - Geneva: World Health Organization; 2011.

208.Alcohol intake and blood pressure: a systematic review implementing a mendelian randomization approach / L. Chen, G. D. Smith, R. M. Harbord, S. J. Lewis // PLoS medicine. -- 2008. -- Vol. 5, No. 3. -- e52p.

209.Показники здоров'я населення та використання ресурсів охорони здоров'я в Україні за 1990-2008 р.р

210.Смертність населення України у трудоактивному віці [монографія / відп. ред. Е. М. Лібанова]. - К.: Ін-т демографії та соц. досліджень НАН України, 2007. -211с.

211.Huisman M. Inequalities in the prevalence of smoking in the european union: comparing education and income / M. Huisman, A. E. Kunst, J. P. Mackenbach // Preventive Medicine. -- 2005. -- Vol. 40, No. 6. -- P. 756-764.

212.Acute effects of passive smoking on blood pressure and heart rate in healthy females / M. Yarlioglues, M. G. Kaya, I. Ardic[et al.] // Blood Pressure Monitoring. -- 2010. -- Vol. 15, No. 5. -- P. 251-256.

213.Mechanisms responsible for sympathetic activation by cigarette smoking in humans / G. Grassi, G. Seravalle, D. A. Calhoun[et al.] // Circulation. -- 1994. -- Vol. 90, No. 1. -- P. 248-253.

214.Cigarette smoking increases sympathetic outflow in humans / K. Narkiewicz, P. J. van de Borne, M. Hausberg[et al.] // Circulation. -- 1998. -- Vol. 98, No. 6. -- P. 528-534.

215.Smoking impairs baroreflex sensitivity in humans / G. Mancia, A. Groppelli, M. Di Rienzo[et al.] // The American Journal of Physiology. -- 1997. -- Vol. 273, No. 3 Pt 2. -- P. H1555-1560.

216.Do we undertreat hypertensive smokers? a comparison between smoking and non-smoking hypertensives / L. E. Bang, L. Buttenschшn, K. S. Kristensen, T. L. Svendsen // Blood Pressure Monitoring. -- 2000. -- Vol. 5, No. 5-6. -- P. 271-274.

217.Association between smoking and blood pressure: evidence from the health survey for england / P. Primatesta, E. Falaschetti, S. Gupta[et al.] // Hypertension. -- 2001. -- Vol. 37, No. 2. -- P. 187-193.

218.Mortality in relation to smoking: 40 years' observations on male british doctors / R. Doll, R. Peto, K. Wheatley[et al.] // BMJ (Clinical research ed.). -- 1994. -- Vol. 309, No. 6959. -- P. 901-911.

219.The risk of myocardial infarction after quitting smoking in men under 55 years of age / L. Rosenberg, D. W. Kaufman, S. P. Helmrich, S. Shapiro // The New England Journal of Medicine. -- 1985. -- Vol. 313, No. 24. -- P. 1511-1514.

220.The primary prevention of myocardial infarction / J. E. Manson, H. Tosteson, P. M. Ridker[et al.] // The New England Journal of Medicine. -- 1992. -- Vol. 326, No. 21. -- P. 1406-1416.

221.Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban japanese population: the suita study / A. Higashiyama, T. Okamura, Y. Ono[et al.] // Circulation Journal: Official Journal of the Japanese Circulation Society. -- 2009. -- Vol. 73, No. 12. -- P. 2258-2263.

222.Doolan D. M. Smoking cessation interventions and older adults / D. M. Doolan, E. S. Froelicher // Progress in Cardiovascular Nursing. -- 2008. -- Vol. 23, No. 3. -- P. 119-127.

223.Относительный риск смертности среди женского населения в связи со статусом курения, употребления алкоголя и уровня образования / В.В. Константинов, С.А. Шальнова, С.В. Киреев [и др.] //Кардиоваскулярная терапия и профилактика. - 2007. -№6,(3). - С.100-1055.

224.Minimum wages statistics [Electronic resource] /Eurostat. - Europen Comission, 2013. - Available from: http:// epp.еurostat.ec. еuropa.eu

225.Резолюция 56-й сессии Всемирной Ассамблеи здравоохранения WHA56.1. Рамочная конвенция ВОЗ по борьбе против табака. - Женева: Всемирная организация здравоохранения, 2003.

226.Centers for Disease Control and Prevention. Best practices for comprehensive tobacco control programs. - Atlanta: CDC, 2007.

227.Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. Changes in Cigarette- Related Disease Risks and Their Implications for Prevention and Control. Smoking and Tobacco Control: мonograph No. 8. Bethesda, MD /M.J. Thun, D.G. Myers, C. Day-Lally [et al.]. //US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. - 1997. - Р.383-413.

228.Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies / J. He, S. Vupputuri, K. Allen[et al.] // The New England Journal of Medicine. -- 1999. -- Vol. 340, No. 12. -- P. 920-926.

229.Lightwood J. M. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke / J. M. Lightwood, S. A. Glantz // Circulation. -- 2009. -- Vol. 120, No. 14. -- P. 1373-1379.

230.How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general / Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US). -- Atlanta (GA) : Centers for Disease Control and Prevention (US), 2010.

231.Lancaster T. Physician advice for smoking cessation / T. Lancaster, L. Stead // The Cochrane Database of Systematic Reviews. -- 2004. -- No. 4. -- CD000165р.

232.Nicotine replacement therapy for smoking cessation / L. F. Stead, R. Perera, C. Bullen[et al.] // The Cochrane Database of Systematic Reviews. -- 2008. -- No. 1. -- CD000146р.

233.Полька Н.С. Поширеність тютюнопаління серед підлітків України /Полька Н.С., Яцковська Н.Я., Гозак С.В. // Довкілля та здоров'я.-2008.-№1,(44).-С.69-73.

234.Edwards R. The problem of tobacco smoking / R. Edwards // BMJ (Clinical research ed.). -- 2004. -- Vol. 328, No. 7433. -- P. 217-219.

235.Smoking and risk of myocardial infarction in women and men: longitudinal population study / E. Prescott, M. Hippe, P. Schnohr[et al.] // BMJ (Clinical research ed.). -- 1998. -- Vol. 316, No. 7137. -- P. 1043-1047.

236.Необходимо ли учитывать психосоциальные особенности населения при планировании и реализации популяционных профилактических программ?: [науч.-практ. рец. мед. журн.] / А.Н. Бритов, Н.А. Елисеева, А.Д. Деев, Е.В. Мирошник // Кардиоваскулярная терапия и профилактика. - 2012. - Т. 11, № 1. - С. 17-22.

237.Equity, social determinants and public health programmes. - Geneva: WHO, 2010.

238.Educational inequalities associated with health-related behaviours in the adult population of singapore / C. W. Fong, V. Bhalla, D. Heng[et al.] // Singapore Medical Journal. -- 2007. -- Vol. 48, No. 12. -- P. 1091-1099.

239.Tamayo T. Impact of early psychosocial factors (childhood socioeconomic factors and adversities) on future risk of type 2 diabetes, metabolic disturbances and obesity: a systematic review / T. Tamayo, H. Christian, W. Rathmann // BMC public health. -- 2010. -- Vol. 10. -- 525р.

240.Cardiovascular disease: Equity and social determinants /[S. Mendis, A.Banerjee; eds.: Blas E, Kurup AS] //Equity, social determinants and public health programmes. - Geneva: World Health Organization, 2010. - Р.31-48.

241.Mookadam F. Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview / F. Mookadam, H. M. Arthur // Archives of Internal Medicine. -- 2004. -- Vol. 164, No. 14. -- P. 1514-1518.

242. Social support and coronary heart disease: epidemiologic evidence and implications for treatment / H. S. Lett, J. A. Blumenthal, M. A. Babyak[et al.] // Psychosomatic Medicine. -- 2005. -- Vol. 67, No. 6. -- P. 869-878.

243.Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis / R. Rugulies // American Journal of Preventive Medicine. -- 2002. -- Vol. 23, No. 1. -- P. 51-61.

244.Wulsin L. R. Do depressive symptoms increase the risk for the onset of coronary disease? a systematic quantitative review / L. R. Wulsin, B. M. Singal // Psychosomatic Medicine. -- 2003. -- Vol. 65, No. 2. -- P. 201-210.

245.Nicholson A. Depression as an a etiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies / A. Nicholson, H. Kuper, H. Hemingway // European Heart Journal. -- 2006. -- Vol. 27, No. 23. -- P. 2763-2774.

246. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the women's health initiative observational study / J. W. Smoller, M. H. Pollack, S. Wassertheil-Smoller[et al.] // Archives of General Psychiatry. -- 2007. -- Vol. 64, No. 10. -- P. 1153-1160.

247.Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study / Y.-H. Chen, S.-Y. Tsai, H.-C. Lee, H.-C. Lin // Psychosomatic Medicine. -- 2009. -- Vol. 71, No. 7. -- P. 798-804.

248.Denollet J. A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type d (distressed) personality profile / J. Denollet, A. A. Schiffer, V. Spek // Circulation. Cardiovascular Quality and Outcomes. -- 2010. -- Vol. 3, No. 5. -- P. 546-557.

249.Telephone-delivered collaborative care for treating post-cabg depression: a randomized controlled trial / B. L. Rollman, B. H. Belnap, M. S. LeMenager[et al.] // JAMA. -- 2009. -- Vol. 302, No. 19. -- P. 2095-2103.

250.Бурмистрова Е.К. Развитие артериальной гипертензии у лиц, подверженных влиянию хронического стресса [Текст]: автореф. дис. канд. мед. наук /Е.К.Бурмистрова. - Самара, 2009. - 16 с.

251.Габдеева Г.Ш. Психологическая защита личности в хронических стрессовых ситуациях/ Г.Ш Габдеева //Уч. Записи Казанского гос. университета. -2007. -Т.19, кн.1. - С.84-94.

252.Чазов Е.И Депрессивная симптоматика ухудшает прогноз у больных артериальной гипертонией и ишемической болезнью сердца: первые результаты перспективного этапа российского многоцентрового исследования КООРДИНАТА / [Чазов Е.И. и др.] //Кардиология. - 2007. -№47(10).-С.24--30.

253.Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial / K. W. Davidson, N. Rieckmann, L. Clemow[et al.] // Archives of Internal Medicine. -- 2010. -- Vol. 170, No. 7. -- P. 600-608.

254.Collaborative care for patients with depression and chronic illnesses / W. J. Katon, E. H. B. Lin, M. Von Korff[et al.] // The New England Journal of Medicine. -- 2010. -- Vol. 363, No. 27. -- P. 2611-2620.

255.Motivational interviewing: a systematic review and meta-analysis / S. Rubak, A. Sandbaek, T. Lauritzen, B. Christensen // The British Journal of General Practice: The Journal of the Royal College of General Practitioners. -- 2005. -- Vol. 55, No. 513. -- P. 305-312.

256.Efficacy of in-hospital multidimensional interventions of secondary prevention after acute coronary syndrome: a systematic review and meta-analysis / R. Auer, J. Gaume, N. Rodondi[et al.] // Circulation. -- 2008. -- Vol. 117, No. 24. -- P. 3109-3117.

257.Linden W. Psychological treatment of cardiac patients: a meta-analysis / W. Linden, M. J. Phillips, J. Leclerc // European Heart Journal. -- 2007. -- Vol. 28, No. 24. -- P. 2972-2984.

258.Psychological interventions for coronary heart disease / K. Rees, P. Bennett, R. West[et al.] // The Cochrane Database of Systematic Reviews. -- 2004. -- No. 2. --CD002902 p.

259.Motivational interviewing / S. Rollnick, C. C. Butler, P. Kinnersley[et al.] // BMJ (Clinical research ed.). -- 2010. -- Vol. 340. --c1900p.

260.Psychosocial treatment within sex by ethnicity subgroups in the enhancing recovery in coronary heart disease clinical trial / N. Schneiderman, P. G. Saab, D. J. Catellier[et al.] // Psychosomatic Medicine. -- 2004. -- Vol. 66, No. 4. -- P. 475-483.

261.Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction / C. B. Taylor, M. E. Youngblood, D. Catellier[et al.] // Archives of General Psychiatry. -- 2005. -- Vol. 62, No. 7. -- P. 792-798.

262.Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (enrichd) study / R. M. Carney, J. A. Blumenthal, K. E. Freedland[et al.] // Psychosomatic Medicine. -- 2004. -- Vol. 66, No. 4. -- P. 466-474.

263.Sauer W. H. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction / W. H. Sauer, J. A. Berlin, S. E. Kimmel // Circulation. -- 2003. -- Vol. 108, No. 1. -- P. 32-36.

264.Stress reduction prolongs life in women with coronary disease: the stockholm women's intervention trial for coronary heart disease (switchd) / K. Orth-Gomйr, N. Schneiderman, H.-X. Wang[et al.] // Circulation. Cardiovascular Quality and Outcomes. -- 2009. -- Vol. 2, No. 1. -- P. 25-32.

265.Joint statement of the european association for the study of obesity and the european society of hypertension: obesity and difficult to treat arterial hypertension / J. Jordan, V. Yumuk, M. Schlaich[et al.] // Journal of Hypertension. -- 2012. -- Vol. 30, No. 6. -- P. 1047-1055.

266.Cornelissen V. A. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors / V. A. Cornelissen, R. H. Fagard // Hypertension. -- 2005. -- Vol. 46, No. 4. -- P. 667-675.

267.Physical activity recommendations and decreased risk of mortality / M. F. Leitzmann, Y. Park, A. Blair[et al.] // Archives of Internal Medicine. -- 2007. -- Vol. 167, No. 22. -- P. 2453-2460.

268.The impact of physical activity on mortality in patients with high blood pressure: a systematic review / A. Rossi, A. Dikareva, S. L. Bacon, S. S. Daskalopoulou // Journal of Hypertension. -- 2012. -- Vol. 30, No. 7. -- P. 1277-1288.

269.Fagard R. H. Physical activity, fitness and mortality / R. H. Fagard // Journal of Hypertension. -- 2012. -- Vol. 30, No. 7. -- P. 1310-1312.

270.Fagard R. H. Exercise therapy in hypertensive cardiovascular disease / R. H. Fagard // Progress in Cardiovascular Diseases. -- 2011. -- Vol. 53, No. 6. -- P. 404-411.

271.Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients / H. E. Molmen-Hansen, T. Stolen, A. E. Tjonna[et al.] // European Journal of Preventive Cardiology. -- 2012. -- Vol. 19, No. 2. -- P. 151-160.

272.Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials / V. A. Cornelissen, R. H. Fagard, E. Coeckelberghs, L. Vanhees // Hypertension. -- 2011. -- Vol. 58, No. 5. -- P. 950-958.

273.Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the eacpr. part ii / L. Vanhees, N. Geladas, D. Hansen[et al.] // European Journal of Preventive Cardiology. -- 2012. -- Vol. 19, No. 5. -- P. 1005-1033.

274.Nutrition and physical activity educational intervention on chd risk factors: a systematic review study / F. Rahmati Najarkolaei, E. Ghaffarpasand, M. Gholami Fesharaki, N. Jonaidi Jafari // Archives of Iranian Medicine. -- 2015. -- Vol. 18, No. 1. -- P. 51-57.

275.Oguma Y. Physical activity decreases cardiovascular disease risk in women: review and meta-analysis / Y. Oguma, T. Shinoda-Tagawa // American Journal of Preventive Medicine. -- 2004. -- Vol. 26, No. 5. -- P. 407-418.

276.Daily total physical activity level and premature death in men and women: results from a large-scale population-based cohort study in japan (jphc study) / M. Inoue, H. Iso, S. Yamamoto[et al.] // Annals of Epidemiology. -- 2008. -- Vol. 18, No. 7. -- P. 522-530.

277.Effects of a community-based healthy heart program on increasing healthy women's physical activity: a randomized controlled trial guided by community-based participatory research (cbpr) / R. Pazoki, I. Nabipour, N. Seyednezami, S. R. Imami // BMC public health. -- 2007. -- Vol. 7. -- 216p.

278.Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis / M. Nocon, T. Hiemann, F. Mьller-Riemenschneider[et al.] // European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. -- 2008. -- Vol. 15, No. 3. -- P. 239-246.

279.Lцllgen H. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories / H. Lцllgen, A. Bцckenhoff, G. Knapp // International Journal of Sports Medicine. -- 2009. -- Vol. 30, No. 3. -- P. 213-224.

280.Schnohr P. Intensity versus duration of walking, impact on mortality: the copenhagen city heart study / P. Schnohr, H. Scharling, J. S. Jensen // European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. -- 2007. -- Vol. 14, No. 1. -- P. 72-78.